The Infection Control market is expected to grow at a CAGR of 6.7% to reach USD 359.6 billion in 2030.
The global Infection Control market was valued at USD 19.7 billion in 2019 and is expected to grow at a CAGR of 6.6% over the forecast period. Growing surgical procedures is projected to fuel market growth over the forecast period.
The global infection control market is categorized based on type, end-use. Region wise, North America was the largest market in 2019 owing to presence of large patient pool coupled with high awareness levels. Asia Pacific on the other is projected to witness fastest growth rate owing to rising demand from emerging economies such as Japan, China, and India. The overall Asia Pacific infection control market is projected to witness a CAGR of 7.3% from 2020 to 2028.
Key players serving the global Infection Control market include 3M, Ecolab, BELIMED, INC., Halyard Health, Inc., Getinge AB, Advanced Sterilization Products, MATACHANA GROUP, MMM Group, Cantel Medical, STERIS plc among other prominent players.
The Infection Control Market Scope
|Revenue forecast in 2030
|USD 359.6 billion
|CAGR of 6.7 % during 2020-2030
|Type, End-use, Regions
|North America, Europe, Asia Pacific, South America, Middle East and Africa
|Key Players Profiled
|3M, Ecolab, BELIMED, INC., Halyard Health, Inc., Getinge AB, Advanced Sterilization Products, MATACHANA GROUP, MMM Group, Cantel Medical, STERIS plc among other
Key Segment Of The Infection Control Market
Type (USD Billion)
? Endoscope Reprocessors
• Sterilization Equipment
? Heat Sterilization Equipment
? Low Temperature Sterilization Equipment
? Radiation Sterilization Equipment
? Filtration Sterilization Equipment
? Liquid Sterilization Equipment
• Contract Sterilization
? Ethylene Oxide Sterilization
? E-beam Sterilization
? Gamma Sterilization
• Infectious Waste Disposal
• Infectious Waste Disposal
• Sterilization Consumables
• Personal Protective Equipment
End-use, (USD Billion)
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Laboratories
Regional Overview, (USD Billion)
• Rest of Europe
• Rest of Asia Pacific
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
The growing number of government initiatives coupled with rising focus on high degree infection control is projected to boost global infection control market growth over the forecast period from 2020 to 2028. Furthermore, rising geriatric population suffering from chronic diseases is anticipated to offer lucrative growth opportunities for the market players across the globe. The growing number of surgical procedures coupled with rising incidence of nosocomial infections are other factors that are anticipated to fuel market growth over the forecast period.
The global infection control market has been bifurcated based on type, and end-use. Based on end-use the global market is further segmented into hospitals, pharma & medical device companies, clinical laboratories, and others. In the year 2019, hospitals segment dominated the global infection control market and is projected to witness the highest growth over the forecast period. The market dominancy is attributed to rising probability of acquiring infections in hospital premises. HAIs are one of the biggest challenges for the hospitals across the globe and there has been a growing focus on tackling this challenge. This is expected to boost infection control market growth over the forecast period.
Based on regions, the global infection control market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa. In the year 2019, North America dominated the global infection control market owing to rising strategic initiative opted by market players across the region in order to widen the product portfolio. However, Asia Pacific infection control market is projected to witness the highest growth rate owing to rising healthcare expenditure, growing government focus on strengthening healthcare infrastructure across the region.